Derfor vil den virksomhed, der fremstiller Kaletra, udsende et brev til dem, der har ansvaret for patienter i behandling med lægemidlet.
As Kaletra was previously available only as capsules and oral solution, the company that makes Kaletra will supply a letter for people involved in the care of patients taking the medicine.